Weekly Ozempic/Wegovy Injections May Lower Kidney Failure Risk
Study reveals that weekly treatment with semaglutides injections such as Ozempic/Wegovy may significantly reduce the risk of kidney failure.
Stay updated with breaking news from Kidney Function Decline. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Study reveals that weekly treatment with semaglutides injections such as Ozempic/Wegovy may significantly reduce the risk of kidney failure.
The 2-year data from the PROTECT study confirms the sustained benefit of sparsentan in patients with IgA nephropathy.
/PRNewswire/ -- Chronic kidney disease (CKD) in children is rare, which makes it difficult to study and leaves major gaps in the quantity and quality of...
Compared with insulin glargine, tirzepatide was associated with significantly less new-onset macroalbuminuria in patients with type 2 diabetes at high cardiovascular risk but mainly normal kidney function.